vs
Finance of America Companies Inc.（FOA）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Finance of America Companies Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$73.5M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -14.1%，领先398.2%），Finance of America Companies Inc.同比增速更快（248.7% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -0.8%）
洛克特公司是一家美国金融科技与住房服务企业，由丹·吉尔伯特创立，总部位于密歇根州底特律市中心。依托核心子公司Rocket Mortgage，该公司已是美国规模最大的抵押贷款机构之一，旗下还拥有Redfin、Forsalebyowner.com、Rocket Money等子品牌。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FOA vs RIGL — 直观对比
营收规模更大
FOA
是对方的1.1倍
$69.8M
营收增速更快
FOA
高出227.5%
21.2%
净利率更高
RIGL
高出398.2%
-14.1%
两年增速更快
RIGL
近两年复合增速
-0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $73.5M | $69.8M |
| 净利润 | $-10.4M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -29.9% | 33.2% |
| 净利率 | -14.1% | 384.0% |
| 营收同比 | 248.7% | 21.2% |
| 净利润同比 | 82.4% | 1769.2% |
| 每股收益（稀释后） | $0.45 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FOARIGL
| Q4 25 | $73.5M | $69.8M | ||
| Q3 25 | $80.8M | $69.5M | ||
| Q2 25 | $177.4M | $101.7M | ||
| Q1 25 | $165.7M | $53.3M | ||
| Q4 24 | $-49.4M | $57.6M | ||
| Q3 24 | $290.1M | $55.3M | ||
| Q2 24 | $79.0M | $36.8M | ||
| Q1 24 | $74.7M | $29.5M |
净利润FOARIGL
| Q4 25 | $-10.4M | $268.1M | ||
| Q3 25 | $-9.5M | $27.9M | ||
| Q2 25 | $34.9M | $59.6M | ||
| Q1 25 | $30.2M | $11.4M | ||
| Q4 24 | $-59.1M | $14.3M | ||
| Q3 24 | $84.2M | $12.4M | ||
| Q2 24 | $-2.1M | $-1.0M | ||
| Q1 24 | $-7.5M | $-8.2M |
毛利率FOARIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FOARIGL
| Q4 25 | -29.9% | 33.2% | ||
| Q3 25 | -35.3% | 40.9% | ||
| Q2 25 | 46.2% | 60.1% | ||
| Q1 25 | 49.3% | 23.9% | ||
| Q4 24 | 295.0% | 28.9% | ||
| Q3 24 | 71.8% | 25.4% | ||
| Q2 24 | -4.8% | 1.2% | ||
| Q1 24 | -21.1% | -23.6% |
净利率FOARIGL
| Q4 25 | -14.1% | 384.0% | ||
| Q3 25 | -11.8% | 40.2% | ||
| Q2 25 | 19.7% | 58.6% | ||
| Q1 25 | 18.2% | 21.5% | ||
| Q4 24 | 119.5% | 24.9% | ||
| Q3 24 | 29.0% | 22.5% | ||
| Q2 24 | -2.6% | -2.8% | ||
| Q1 24 | -10.1% | -27.9% |
每股收益（稀释后）FOARIGL
| Q4 25 | $0.45 | $14.11 | ||
| Q3 25 | $-1.27 | $1.46 | ||
| Q2 25 | $2.13 | $3.28 | ||
| Q1 25 | $2.43 | $0.63 | ||
| Q4 24 | $-5.24 | $0.82 | ||
| Q3 24 | $7.50 | $0.70 | ||
| Q2 24 | $-0.30 | $-0.06 | ||
| Q1 24 | $-0.78 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.5M | $155.0M |
| 总债务越低越好 | $357.5M | $52.5M |
| 股东权益账面价值 | $395.6M | $391.5M |
| 总资产 | $30.7B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.90× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FOARIGL
| Q4 25 | $89.5M | $155.0M | ||
| Q3 25 | $109.8M | $137.1M | ||
| Q2 25 | $46.5M | $108.4M | ||
| Q1 25 | $52.0M | $77.1M | ||
| Q4 24 | $47.4M | $77.3M | ||
| Q3 24 | $44.3M | $61.1M | ||
| Q2 24 | $46.5M | $49.1M | ||
| Q1 24 | $48.2M | $49.5M |
总债务FOARIGL
| Q4 25 | $357.5M | $52.5M | ||
| Q3 25 | $390.0M | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | $374.5M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益FOARIGL
| Q4 25 | $395.6M | $391.5M | ||
| Q3 25 | $365.8M | $117.6M | ||
| Q2 25 | $473.4M | $81.9M | ||
| Q1 25 | $394.9M | $18.6M | ||
| Q4 24 | $315.7M | $3.3M | ||
| Q3 24 | $456.5M | $-14.6M | ||
| Q2 24 | $251.3M | $-29.9M | ||
| Q1 24 | $255.7M | $-31.7M |
总资产FOARIGL
| Q4 25 | $30.7B | $513.6M | ||
| Q3 25 | $30.7B | $242.5M | ||
| Q2 25 | $30.1B | $206.7M | ||
| Q1 25 | $29.7B | $176.0M | ||
| Q4 24 | $29.2B | $164.0M | ||
| Q3 24 | $29.0B | $139.4M | ||
| Q2 24 | $28.0B | $128.4M | ||
| Q1 24 | $27.7B | $126.5M |
负债/权益比FOARIGL
| Q4 25 | 0.90× | 0.13× | ||
| Q3 25 | 1.07× | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | 1.19× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-429.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FOARIGL
| Q4 25 | $-429.7M | $22.0M | ||
| Q3 25 | $-149.7M | $24.0M | ||
| Q2 25 | $-96.5M | $30.5M | ||
| Q1 25 | $-92.1M | $-893.0K | ||
| Q4 24 | $-423.8M | $14.5M | ||
| Q3 24 | $-81.4M | $21.7M | ||
| Q2 24 | $-104.0M | $302.0K | ||
| Q1 24 | $-132.2M | $-5.0M |
自由现金流FOARIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-132.7M | — |
自由现金流率FOARIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -177.7% | — |
资本支出强度FOARIGL
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.6% | — |
现金转化率FOARIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | -2.76× | 0.51× | ||
| Q1 25 | -3.05× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -0.97× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOA
| Segment Continuing Operations | $70.8M | 96% |
| Other | $2.7M | 4% |
RIGL
暂无分部数据
